(Q44041578)

English

Antipsychotic profile of 5-[2-[4-(6-fluoro-1H-indole-3-yl)piperidin-1-yl]ethyl]-4-(4-fluorophenyl)thiazole-2-carboxylic acid amide (NRA0562) in rats

scientific article published in July 2002

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Antipsychotic profile of 5-[2-[4-(6-fluoro-1H-indole-3-yl)piperidin-1-yl]ethyl]-4-(4-fluorophenyl)thiazole-2-carboxylic acid amide (NRA0562) in rats (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

1 reference

based on heuristic

inferred from title

author name string

Kazuaki Takamori

1

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Takeo Funakoshi

2

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Shiho Hirota

3

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Shigeyuki Chaki

4

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Kazuya Kameo

5

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

language of work or name

0 references

publication date

1 July 2002

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

71

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

947-952

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Differential effects of neuroleptic and other psychotropic agents on acquisition of avoidance in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901766-6

7 January 2021

Potency mismatch for behavioral and biochemical effects by dopamine receptor antagonists: implications for the mechanism of action of clozapine

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901766-6

7 January 2021

Minireview A systematic study of the pharmacological activities of dopamine antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901766-6

7 January 2021

Neuropharmacological profiles of a novel atypical antipsychotic, NRA0562, in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901766-6

7 January 2021

Clinical studies on the mechanism of action of clozapine: the dopamine-serotonin hypothesis of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901766-6

7 January 2021

Effect of serotonin antagonism in schizophrenia: a pilot study with setoperone.

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901766-6

7 January 2021

Mode of action of atypical neuroleptics in relation to the phencyclidine model of schizophrenia: role of 5-HT2 receptor and alpha 1-adrenoceptor antagonism [corrected]

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901766-6

7 January 2021

Enhancement of antipsychotic-like properties of the dopamine D2 receptor antagonist, raclopride, by the additional treatment with the 5-HT2 receptor blocking agent, ritanserin, in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901766-6

7 January 2021

Enhancement of antipsychotic-like effects by combined treatment with the alpha1-adrenoceptor antagonist prazosin and the dopamine D2 receptor antagonist raclopride in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901766-6

7 January 2021

Performance on a lever-release, conditioned avoidance response task involves both dopamine D1 and D2 receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901766-6

7 January 2021

Different inhibition of conditioned avoidance response by clozapine and DA D1 and D2 antagonists in male mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901766-6

7 January 2021

7-Methyl-6,7,8,9,14,15-hexahydro-5H-benz[d]indolo[2,3-g]azecine: a new heterocyclic system and a new lead compound for dopamine receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901766-6

7 January 2021

Determination of plasma and brain concentrations of SCH 39166 and their correlation to conditioned avoidance behavior in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901766-6

7 January 2021

Identifiers

10.1016/S0024-3205(02)01766-6

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44041578&oldid=2108711810"